Dynulta Tablet: Ultimate Performance and Reliability

Dynulta Tablet

Active component: sucroferric oxyhydroxide.

Classification: phosphate binder.

Use:

• Treatment of hyperphosphatemia in patients with chronic kidney disease (CKD) who are on dialysis. Hyperphosphatemia is characterized by abnormally high levels of phosphate in the blood.

Mechanism of action:

• By binding to dietary phosphate in the gastrointestinal tract, Dynulta Tablet prevents its absorption into the bloodstream, thereby reducing the overall phosphate burden.
• This helps to manage hyperphosphatemia and minimize associated risks such as bone disease and cardiovascular complications.

Contraindications:

• Do not take Dynulta Tablet if you are allergic to it or its components.
• Patients with iron overload disorders, such as hemochromatosis, or those receiving high-dose intravenous iron therapy should use Dynulta Tablet cautiously.
• The use of this medicine in pediatric patients has not been extensively studied.

Dosage and administration:

• Follow the instructions provided by your healthcare professional or the guidelines on the medication packaging.
• Typically, this medication is taken orally as chewable tablets with meals or shortly after eating.
• The dosage and frequency of administration will depend on your specific medical condition and individual needs.
• Chew the tablets thoroughly before swallowing.

Safety advice:

• Pregnancy: the safety of Dynulta Tablet during pregnancy has not been well established. Caution is advised when considering the use of this medication during pregnancy.
• Breastfeeding: the safety of Dynulta Tablet during breastfeeding has not been well studied. Caution is advised when considering the use of breastfeeding.
• Lungs: Dynulta Tablet is not known to have specific safety concerns related to the lungs.
• Liver: the safety of Dynulta Tablet in individuals with liver disease has not been extensively studied.
• Alcohol: excessive alcohol consumption can negatively affect your health, especially if you have underlying liver disease or other medical conditions.
• Driving: Dynulta Tablets can cause side effects that may impair your ability to drive or operate machinery safely.

Side effects:

• Serious: allergic reaction, breathlessness, black stools.
• Common: diarrhea, discolored feces (usually dark or black), constipation, nausea, vomiting, stomach pain or discomfort, indigestion or heartburn.

FAQs:

1. Can Dynulta Tablet cause interactions with certain laboratory tests or diagnostic procedures?
   • Dynulta tablets may interfere with certain laboratory tests that measure iron or phosphate levels. Inform healthcare professionals performing these tests that you are taking this medication.
2. Can Dynulta Tablet be used in patients with kidney dysfunction?
   • Dynulta Tablet is primarily used in patients with chronic kidney disease who are on dialysis. In patients with severe kidney dysfunction who are not on dialysis, the use of this medication may need to be carefully evaluated by a healthcare provider.
3. Can Dynulta Tablet be used in patients with a history of gastrointestinal bleeding or ulcers?
   • The use of Dynulta Tablet in patients with a history of gastrointestinal bleeding or ulcers should be cautiously approached. Discuss your medical history with your healthcare provider.
4. Can Dynulta Tablet be used in elderly patients?
   • Dynulta Tablets can be used in elderly patients; however, caution should be exercised due to the increased likelihood of age-related conditions and potential interactions with other medications.
5. Can Dynulta Tablet be used long-term?
   • Dynulta Tablet is often used as a long-term treatment for chronic kidney disease in patients on dialysis. Your healthcare provider will determine the duration of treatment based on your individual needs and response to therapy.
6. What should I do if I experience side effects while taking Dynulta Tablet?
   • Report any side effects to your healthcare provider promptly. They can evaluate the symptoms and determine the appropriate course of action.

Storage:

• Store at controlled room temperature, between 20°C to 25°C (68°F to 77°F).
• Keep away from moisture, heat, and light.
• Do not freeze.
• Keep away from children and pets.

Tags: tablet, dynulta, electronics, computer-accessories, mobile-device